<DOC>
	<DOCNO>NCT00441675</DOCNO>
	<brief_summary>The CATO population well document population two year . During study patient treat accord CATO algorithm , patient treat accord Dutch national ( GINA derive ) guideline 6 year follow-up . The purpose prospective follow-up study understand long-term effect treatment . Therefore measurement do baseline ( CATO part 1 ) repeat 6 year CATO-population ( CATO follow-up ) .</brief_summary>
	<brief_title>A Long Term Prospective Follow Up Study For The CATO Study ( SAS30018/SER9702 )</brief_title>
	<detailed_description>A long term follow study comparison stepwise treatment asthmatic child Salmeterol/Fluticasone propionate combination product ( Seretide® ) and/or Fluticasone propionate ( Flixotide® ) base PD20 methacholine symptom base symptom ( `` Children Asthma Therapy Optimal '' )</detailed_description>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<criteria>Inclusion criterion : Any subject give informed consent participate CATO study , meet criterion require randomisation clinical study may take part follow study Under age 18 year Subjects parent ( ) /guardian ( ) give write informed consent participate study Subjects 18 year old give write informed consent participate study Exclusion criterion : Experienced acute asthma exacerbation require emergency room treatment within 4 week hospitalisation within 4 week visit 1 Any use oral/parenteral depot corticosteroid within 4 week visit 1 Subjects pregnant ( pregnancy test perform investigator 's discretion )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Adolescents</keyword>
	<keyword>Asthma</keyword>
	<keyword>long-term follow-up</keyword>
	<keyword>symptom</keyword>
	<keyword>bronchial hyperresponsiveness</keyword>
</DOC>